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Endothelial hypoxic stress proteins
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Pulrnonaiy Cente,; Boston University School of Medicine, Boston, Massachusetts, USA
Decreased environmental oxygen concentration is a frequent
stress in both health and disease. Defining the mechanisms by
which mammalian cells and organisms respond and adapt to acute
and chronic decreases in environmental oxygen is critical to
understanding the maintenance of homeostasis and the pathogen-
esis of diseases involving hypoxia. Among the numerous cell types
in which tolerance and adaptation to hypoxia are likely crucial to
survival are vascular endothelial cells (EC), since they are fre-
quently and directly exposed to decreases in blood oxygen tension.
For example, venous and pulmonary arterial EC are continually
exposed to low levels of oxygen (PO2 of 40 to 45 torr) due to the
oxygen content of mixed venous blood and, during pathologic
states, may be exposed to even lower levels (such as P°2 of 20 to
25 torr). The ability of EC to synthesize and rclease various
mitogenic, pro-coagulant, vasoactive and immunologic mediators,
and the adaptive strategies these cells have developed to tolerate
wide variations in environmental oxygen availability is critical to
maintaining homeostasis, while in certain instances contributing
to the pathogenesis of disease.
Endothelial cells from various vascular beds induce a number of
genes in response to hypoxia. For example, they have been shown
to: (1) increase endothelin mRNA and the release of endothelin
[1]; (2) increase platelet-derived growth factor B message levels
[2]; (3) increase interleukin (IL) 1 activity and mRNA levels [31;
(4) increase IL-8 release and mRNA levels [4]; (5) increase
xanthine dehydrogenase/xanthine oxidase mRNA and activity [5];
(6) alter production of cyclo-oxygenase metabolites [6]; (7) in-
crease uptake of serotonin [7]; (8) increase production of fi-
bronectin and a 100 kDa membrane-associated protein that
appears to activate Factor X [8]; (9) increase synthesis of tropo-
myosin [9]; (10) increase the fluidity of their plasma membrane
and alter membrane fatty acids and phospholipids [10, 11]; and
(11) increase glucose transporter activity [12].
Perhaps in response to their unique location and function EC
are relatively hypoxia tolerant 16—8, 13, 14]. Studies of bovine
aortic (BAEC) and pulmonary artery (BPAEC) EC in culture
show that they can survive up to five days in 0% oxygen (02) and
several months in 3% 0,. Although little is known about how
these cells sense hypoxia and maintain their cellular functions,
several recent studies have linked their hypoxia tolerance to
underlying modes of energy metabolism. These studies have
shown that EC operate under mainly glycolytic metabolism and
possess a large capacity to increase this metabolism [15, 16]. For
instance, aortic and pulmonary artery EC exposed to hypoxia
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exhibit enhanced glycolytic activity that is sufficient to maintain
relatively normal levels of ATP [15]. However, glycolytic activity is
not markedly increased in EC until extremely low levels of 02 are
achieved. For example, coronary EC exposed to hypoxia do not
alter their respiration until the environmental P°2 falls below 3
torr [16].
It is unclear if EC use any of the othcr strategies developed by
many invertebrates and lower vertebrates, such as lungfish and
diving turtles, to overcome limited environmental oxygen supplies
[17—20]. These hypoxia tolerant measures include: (1) storing
large amounts of fermentable fuel; (2) maintaining a high toler-
ance to metabolic acidosis and/or instituting compensatory ion
changes that retard the development of acidosis; (3) depressing
their metabolic rate; and (4) improvement in handling of intra-
cellular calcium [171. Among these potential strategies, the most
effective are metabolic rate suppression and reduced membrane
permeability. By virtue of these strategies (termed metabolic and
channel arrest), hypoxia tolerant organisms, tissues or cells do not
have to compensate for the energy deficit arising from a lack of
oxygen. Thus, despite lower energy turnover, they are able to
retain coupled metabolic and membrane functions by maintaining
membranes of low permeability (possibly via reduced functional
densities of ion-specific channels). In addition, by decreasing
metabolic demands they decrease the need for ATP, preserve
energy substrate, and limit build up of toxic or acidic metabolic
end products during periods of oxygen deprivation.
Unlike many invertebrates and lower vertebrates most mam-
malian cells are relatively hypoxia sensitive and their strategies for
coping with oxygen depletion are limited. In mammalian cells,
glucose and oxygen consumption are inversely related (Pasteur
effect); under conditions in which oxygen is limited, there is a
dramatic rise in the demand for glucose in order to maintain ATP
turnover at a level similar to that during normoxia. Because of
energy insufficiency and increasing membrane permeability, elec-
tric and ion potentials cannot be maintained. Under these condi-
tions a progressive uncoupling of metabolic and membrane func-
tions ensues, eventually resulting in irreversible cell damage. It
may be that EC are able to partially suppress their metabolic rate
and glucose demand in response to hypoxia and thus survive
longer than other mammalian cells.
A generalized response to many cellular stresses, which may or
may not he related to hypoxia tolerance, is the induction of heat
shock (HSP) and/or glucose-regulated (GRP) proteins [21—23].
Classically, they have been described following exposure to in-
creased environmental temperatures (HSPs) and glucose depri-
vation (GRPs). Although their exact function is unclear, these
proteins appear to be involved in maturation and/or repair of
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Fig. 1. Time course of protein induction by hypoxia in BAEC and BPAEC. Cells were maintained in 21% °2 (Cont) or exposed to 0% °2, for the times
indicated. Following hypoxic exposure cells were placed in 21% 02, for a two-hour recovery period then labeled for one hour with [35S1-methionine.
Washed cells were then solubilized in Laemmli sample buffer, boiled and run on 10% SDS-PAGE, loading equal counts per lane. The positions of MW
standards are shown at the left and positions of induced proteins at the right in kDa.
Table 1. Summary of the response of BAEC and BPAEC to different
stresses
Stress Induced proteins (molecular wt in kDa)
Heat shock 65—68, 70—73, 90, 98, 110
Arsenite 32, 66, 68, 70, 90, 98, 110
Glucose deprivation 78, 104
2-DG 40, 41, 78, 104
NaCN No induction
DY!' 78, 104
H202 No induction
Hypoxia 34, 36, (39) 47, 56
Abbreviations are: 2-DO, 2-deoxyglucose; NaCN, sodium cyanide;
DY!', dithiothreitol; H202, hydrogen peroxide.
a Up-regulation of 39 kDa protein during hypoxia is inconsistent and
depends on the EC line examined
nascent and damaged proteins [21—231. Most cell types studied,
including Chinese hamster ovary cells, mouse mammary tumor
cells, rat embryo cells, rat fibroblasts, myogenic cells, and cardiac
and brain tissue, respond to hypoxia by inducing HSP and/or GRP
synthesis [24—28]. In some cells their induction has been linked to
the acquisition of thermotolerance [29, 30]; however, it is not clear
whether these proteins play a role in hypoxia tolerance.
Since some stress proteins induced under other conditions have
been shown to contribute to tolerance of that stress, we and others
have studied the hypoxic response of mammalian cells by inves-
tigating the proteins that are induced following exposure to
varying lengths and intensities of hypoxia. Exposure of cultured
BAEC and BPAEC to hypoxia causes a time and oxygen-
concentration dependent decrease in total protein synthesis.
Despite a 30 to 60% decrease in total protein synthesis, a specific
set of proteins, termed hypoxia-associated proteins (HAPs), are
induced [13, 14]. These proteins have molecular weights of 34, 36,
39, 47, and 56 kDa by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and, although each protein is con-
stitutively expressed in normoxic ECs, they are up-regulated
three- to fivefold following 18 hours of exposure to 0% oxygen
(Figs. 1 and 2). Up-regulation is first detected following four
hours of hypoxia, is maximal at 18 hours of hypoxia and remains
elevated for at least 24 to 48 hours of hypoxic exposure. When
hypoxic ECs are returned to normoxic conditions HAP levels
return to baseline within 12 hours. Induction of HAP synthesis is
inversely related to oxygen concentration with maximal up-regu-
lation occurring with exposure to 0% 02 (P02 in the media of 25
mm Hg). Like other stress proteins, HAPs remain cell associated;
however, they are distinct from HSPs and GRPs by molecular
weight and p1. Endothelial cells cultured long term (such as 2 to
3 months) in 3% °2 (P02 in the media of 45 torr) synthesize
HAPs at a chronically elevated level compared to normoxic cells
of the same cell line and passage number [13]. When these cells
are exposed acutely to 0% °2 they up-regulate HAPs even further
[13, 31].
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Fig. 2. Quantitation of HAP induction by hypoxia according to cell type.
Autoradiograms were analyzed by densitometiy using actin as a control
for each lane. The degree of up-regulation of the 34 kDa protein is shown
1 in (A), that of the 36 kDa protein in (B), that of the 47 kDa protein in (C),0 0 0 0 0 0 0 Ui that of the 56 kDa protein in (D), and that of all four proteins combinedwwwUiwH H in (E). Values arc expressed as means of protein density for individualI I — experiments, N = 3 to 6 for individual proteins and N = 8 to 24 for
combined proteins; *J) < 0.05 for that cell type in comparison to all other
Cell type ccli types; P < 0.05 for that EC type in comparison to all non-PC types).
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Fig. 3. Time course of protein induction by
hypoxia in HMEC. Cells were maintained in
21% 02 (Cont) or exposed to 0% 02 for the
times indicated. Following hypoxic exposure
cells were placed in 21% 02 for a two hours
recovery period, then labeled for one hour with
[35S1-methionine. Washed cells were then
solubilized in Laemmli sample buffer, boiled
and run on 10% SDS-PAGE, loading equal
radioactive counts per lane. The positions of
molecular weight standards are shown at the
left and positions of induced proteins at the
right.
Table 2. Protein induction by hypoxia in different cell types
Cell type Induced proteins (MW in kD)
EC 34, 36, (39), 47, 56
SMC 32, 69, 71, 78, 94
IMR-90 70, 78, 110
T2 59, 70, 71, 76, 90, 110
RTE No induction
Ahbrcviaitons are: EC, endothelial cells; SMC, pulmonary artery
smooth muscle cells; IMR-90, human lung fibroblasts; T2, pulmonary
alveolar type If cells; RTE, renal tubular epithelial cells.
Up-regulation of the 39 kDa protein during hypoxia is inconsistent and
depends on the EC line examined.
To investigate whether HAPs are specifically induced by envi-
ronmental hypoxia we exposed BAEC and BPAEC to various
other forms of stress (Table 1) [14]. Sodium cyanide (NaCN)
irreversibly blocks oxidative phosphorylation and has been used as
a form of chemical hypoxia. Exposure of EC to NaCN had little
affect on the up-regulation of specific proteins. EC exposed to
glucose-free media, 2-deoxyglucose (2-DG), an inhibitor of glyco.
lysis and glycosylation, or the reducing agent dithiothreitol (DTT')
caused up-regulation of two proteins with molecular weights of 78
and 104 kDa, corresponding to GRPs but not to HAPs. In
addition, 2-DG caused up-regulation of two proteins of molecular
weights 40 and 41 kDa. Finally, exposing EC to oxidant stress
using H207 did not induce specific protein synthesis. Endothelial
cells exposed to heat shock or sodium arsenite induced proteins
with molecular weights corresponding to HSPs. None of the above
agents caused induction of proteins of similar MWs to those seen
with hypoxia. Thus, a decrease in oxygen tension itself appears to
be a unique stress for EC and presumably does not induce HAP
synthesis by altering the redox potential of the cell, by causing
glucose deprivation, or by inhibiting oxidative phosphoiylation or
glycolysis.
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To investigate the cell specificity of HAP up-regulation we
exposed different cell types to hypoxia [13, 14]. We had noted
previously that HAP up-regulation was not significantly different
between BAEC and BPAEC (Figs. 1 and 2). To test this phenom-
enon in human cells we exposed human aortic (HAEC), pulmo-
nary artery (HPAEC) and microvascular (adipocyte) (HMEC)
endothelial cells to the same time course of 0% 02 exposure. Like
the bovine cells, human ECs up-regulated HAPs in the same
time-dependent manner, although the intensity of up-regulation
was slightly less (approximately 3-fold, Figs. 2 and 3). Likewise,
there was no significant difference between ECs from different
vascular beds. Previous reports have shown that other cell types,
such as Chinese hamster ovary or mouse mammary tumor cells,
induce synthesis of HSPs or GRPs when exposed to hypoxia
[24—281. To evaluate the response of other cell types to hypoxia in
our system we exposed pulmonary artery smooth muscle (SMC),
fetal lung fibroblasts (IMR-90), pulmonary alveolar type II (T2),
and renal tubular epithelial cells (RTE) to 0% 02 for varying
lengths of time [14]. In response to hypoxia all of these cell types
except RTEs up-regulated proteins of molecular weights corre-
sponding to those of HSPs and/or GRPs (Table 2). Renal tubular
Fig. 4. (A) Ejfect of hypoxia on Tiypan blue exclusion in different cell types.
Cells were maintained in 21% 02 or exposed to 0% 0 for the time indicated.
At the specified times media were removed and replaced with Tiypan blue in
phosphate buffered saline. Following a five-minute incubation period Tiypan
blue exclusion was assessed by light microscopy. Control cells assessed in
parallel maintained 98 to 100% Tiypan blue exclusion throughout the
experiment. Symbols arc: (0) EC; (S) T2; (U) SMC; (A) TMR; (A) RTE. (B)
Effect of hypoxia on chromium release from different cell types. Cells were
labeled overnight with 5tchromium and then either maintained in 21% 02 or
exposed to 0% °2 for the time indicated. At the specified times radioactivity
in the media from the control and hypoxic cells was measured and chromium
release expressed as % above control. Values for each time point are means
of 3 experiments + SCM. The rise in chromium release from RTE was so rapid
that it could not be included in this graph. Chromium release was not an
accurate reflection of cellular injury for T2 cells and was not included.
Symbols are: (0) EC; (U) SMC; (A) IMR-90. (C) Effect of hypoxia on
adherent cell counts of different cell types. Cells were maintained in 21% 02
or exposed to 0% 02 for the time indicated. At the specified times the media
was removed and adherent cells counted by hemocytometer following
trypsinization. Hypoxic cell counts were expressed as a % of normoxic counts
for parallel cultures. Values for each time point are means of 3 experhnents
SCM. Symbols are: (0) EC; (•) T2; (•) SMC; (A) IMR-90.
epithelial cells died rapidly and did not up-regulate any proteins.
None of the non-endothelial cell types up-regulated proteins of
molecular weights corresponding to HAPs (Fig. 2, Table 2).
Since the EC response to hypoxia was different from that of
other cell types, we examined the survival of EC during hypoxia
and compared this to the survival of the other cell types studied
above [14]. Cell survival was assessed by light microscopic appear-
ance, trypan blue exclusion, chromium release and adherent cell
counts. Of the cell types studied, EC were the most hypoxia
tolerant, surviving at least 96 hours in 0% 02 (Fig. 4). The RTEs
were the most sensitive to hypoxia, showing profound deteriora-
tion after eight hours of hypoxic exposure while IMR-90 cells,
SMCs, and T2 cells demonstrated increasing hypoxia tolerance,
respectively. When EC were returned to normoxia after pro-
longed hypoxia, they remained viable and resumed proliferation.
These findings of pronounced EC tolerance to hypoxia confirmed
previous literature reports [6—8, 131. Initial studies have shown
that EC grown chronically in 3% 02 and exposed to 0% 02 for
prolonged periods survive (and, in fact, proliferate) for even
longer periods than do normoxie cells exposed to 0% 02. Al-
though it is unclear whether HAP upregulation contributes to EC
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Fig. 5. Identification of HA P47 as non-neuronal enolase (aa). Normoxic BAEC were maintained in 21% °2 (C) or exposed to 0% 02 for 18 hours (H).
H446 cells (S), a human small-cell lung cancer line co-expressing both a and y subunits, served as a positive control. Whole cell lysates were separated
by SDS-PAGE and transferred to nitrocellulose. Western blot analyses were performed with a polyclonal antibody directed against both the a and y
subunits (A) and a monoclonal antibody specific for the y subunit (B). Protein levels were assessed using chemiluminescence, autoradiography and
densitometry.
A
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GAPDH
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Fig. 6. Analysis of GAPDH mRNA levels during
B hypoxia in different EC types. Control EC were
500 maintained either in 21% 02 or 3% 02.Parallel cultures of experimental EC were
exposed to 0% 02 for 18 hours then placed in
21% 02 for a one hour recovery period. Total
400 RNA was separated on a 1% agarose-
formaldehyde gel, and transferred to a nylon
membrane. This was hybridized with a human
.
-
GAPDH cDNA probe (above) and a 28S
300 rihosomal RNA oligonucleotide probe (below).
Densitometric values for GAPDH message in
E each cell type and condition are normalized to28S rihosomal RNA levels and expressed as
a 200 percent of control levels for that experiment.
Lane 1, BAEC grown chronically in 3% 02;
o lane 2, BAEC grown chronically in 3% °2 and
exposed to 0% °2 for 18 hours; lane 3, BPAEC
grown chronically in 3% 02; lane 4, BPAEC
grown chronically in 3% 02 and exposed to 0%
02 for 18 hours; lane 5, BAEC grown
0 chronically in 21% 0,; lane 6, BAEC grown
3%BA 3%BA 3%PA 3%PA 21 %BA 21 %BA 21 %PA 21 %PA for 18 hours; lane 7, BPAEC grown hronicaily
+ + + + in 21% 0,; lane 8, BPAEC grown chronically0% 18 hr 0%18 hr 0% 18 hr 0% 18 hr in 21% 0, and exposed to 0% °2 for 18 hours.
hypoxia tolerance, their time course of induction correlates with begun purification and sequencing of these proteins. Using urn-
hypoxia tolerance. ited N-terminal amino acid sequencing of the whole protein or
To further characterize the EC response to hypoxia we have tryptic fragments we have identified the 36 kDa protein as the
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glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) [311 and the 47 kDa protein as the glycolytic enzyme,
non-neuronal enolase (NNE) [321.
GAPDH catalyzes the conversion of glyceraldehyde-3-phos-
phate to 1,3-bisphosphoglycerate, thus generating a high energy
phosphate compound in an oxidation-reduction reaction [331.
Although not the primary regulatory site for glycolysis, the activity
of GAPDH is inhibited by several glycolytic metabolites and other
small molecules, and by the association with cell membranes [34,
51 Little is known about the regulation of GAPDH gene
expression by hypoxia; however, the genomic DNA sequence has
been determined in a number of different species and several
regulatory regions have been identified. In general, the GAPDH
sequence is highly conserved and the protein is constitutively
expressed. To date several substances, including insulin [36, 37],
interleukin-2 [38], and hypoxia [31, 39, 401, have been shown to
up-regulate GAPDH gene expression. GAPDH is also up-regu-
lated in certain developing cells, including fast-twitch muscles in
which it is up-regulated twentyfold [33, 40j.
Enolase catalyzes the ninth step in glycolysis, the interconver-
sion of 2-phosphoglycerate to phosphoenolpyruvate. Higher ver-
tebrates possess three enolasc genes, encoding a, and y subunits
[41]. Non-neuronal enolase, a homodimer of 47 kDa a subunits, is
the major isoform during embryogenesis and persists in nearly
every adult tissue [42, 43]. The y subunit, also 47 kDa, is found in
the yy and ay dimers known collectively as neuron-specific
enolase (NSE) [44, 51. NSE is expressed mainly in normal and
neoplastic cells of neuronal and neuroendocrine origin [46, 71
but has been found in diverse mammalian cell types [48, 49]. NSE
has not been found in EC [49] nor has it previously been studied
during exposure to hypoxia. The f3 subunit forms the homodimeric
muscle specific enolase (MSE). It is of a different molecular
weight than HAP47 (44 kDa) and is found only in heart and
skeletal muscle.
Since MSE is specific for muscle and composed of lower
molecular weight subunits than HAP47, it was not investigated
further. However, both NSE and NNE contain 47 kDa subunits
and share significant identity with the HAP47 amino acid se-
quence. To determine whether one or both of these isoforms is
HAP47, Western blot analyses with cnolase antibodies were
performed. Because a monoclonal antibody specific for the eno-
lase a subunit is not commercially available, the protein-contain-
ing nitrocellulose membranes were hybridized with a polyclonal
antibody directed against the a subunit but known to cross-react
with the y subunit. The membrane was then washed and re-
hybridized with a monoclonal antibody specific for the y isomer.
Lysates from H446, a human small-cell lung cancer line which
co-expresses NSE and NNE, served as a positive control (Fig. 5).
These studies showed that NSE is not present in either normoxic
or hypoxic EC and that HAP47 is NNE.
To determine whether the increased levels of GAPDH and
NNE proteins corresponded to increased message levels, we
compared GAPDH and NNE mRNA levels in EC grown chron-
ically in 21% 02 or 3% 02 and exposed acutely to 0% 02 (Figs.
6 and 7) [31, 32]. In all hypoxic EC GAPDH and NNE mRNA
levels increased significantly. BPAEC maintained chronically in
21% 02 and exposed to 18 hours of 0% 02 showed the largest
increase in mRNA levels (4.5-fold for GAPDH and 3.4-fold for
NNE). Comparison of GAPDH and NNE mRNA levels between
21% 02 and 3% °2 cells showed a three- to tenfold increase;
iii01010000
uJ w w w
Q_ 0_
C'J C•'J —(\J (\J
Fig. 7. Analysis of NNE mRNA levels during hypoxia in different EC types.
A. Control BAF.C and BPAEC were maintained in either 3% 02 or 21%
°2 (C). Parallel cultures of BAEC and BPAEC maintained in either 3%
°2 or 21°A °2 were subsequently exposed to 0%07 for 18 hours (H) as
described in Figure 6. Total RNA was separated on a 1 a/ agarosc-
formaldehyde gel, and transferred to a nylon membrane. This was then
hybridized with a human NNE cDNA probe (top) and a 28S ribosomal
RNA oligonucleotide probe (bottom). Densitometric values for NNE
mRNA levels were normalized to 28S rihosomal RNA levels and ex-
pressed as a percent of control levels. B. Densitometric control levels of
NNE mRNA for each cell type and baseline condition are compared with
NNE mRNA levels after exposure to 0% 02. C. Densitometric levels of
NNE mRNA for each cell type and condition arc compared with normoxic
BPAEC maintained in 21% 02 (21% BPAEC-C).
a. ..pn• .4GAPDH A
Actin
400 B
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Fig. 8. Time course of GAPDH mRNA levels
during hypoxia. A. BAEC were either
maintained in 21% 02 (0) or exposed to
increasing periods of 0% 02 followed by a one
hour recoveiy period in 21% 02. Total RNA
was separated on a 1% agarose-formaldehyde
gel and transferred to a nylon membrane. This
was then hybridized with a human GAPDH
eDNA probe (above) or a f3-actin eDNA
(below). B. Densitometric values for GAPDH
message are normalized to -actin levels and
expressed as percent of control levels. Lane 1,
control cells; lane 2, one hour of 0% °2; lane
3, two hours of 0% 02; lane 4, four hours of
0% 02; lane 5, eight hours of 0% 02; lane 6, 18
hours of 0% °2; lane 7, 24 hours of 0% 02;
lane 8, 48 hours of 0% 02.
however, these cells were from different cell lines and passage
numbers. In time course experiments we found that GAPDH and
NNE mRNA levels start to increase significantly after two to four
hours of exposure to 0% 02 and become maximal at 18 hours,
correlating with GAPDH and NNE protein induction (Figs. 8 and
9) [31, 321. Nuclear runoff studies demonstrated that the rate of
GAPDH transcription increased approximately 2.5-fold in BAEC
or BPAEC exposed to 0% 02 for 18 hours when compared to
control cells (Fig. 10) [31]. These findings do not account for the
entire accumulation of GAPDH mRNA which increases four- to
4.5-fold and suggest that post-transcriptional events stabilize
GAPDH mRNA during exposure to hypoxia.
Although little is known about the hypoxic regulation of
GAPDH and NNE, even less information exists about the poten-
tial role of GAPDH and NNE up-regulation in cellular hypoxia
tolerance. Although it seems likely that cells would up-regulate
the activity and, presumably the genetic expression, of glycolytic
enzymes in response to hypoxia, preliminary studies do not show
up-regulation of GAPDH or NNE protein expression in cells
other than EC in response to hypoxia. These finding are even
more confusing when combined with the reports that EC glyco-
lytic activity does not change significantly until extreme levels of
hypoxia are reached (1 to 3 torr) [161. These levels of hypoxia are
far below those used in our system.
Recent studies have suggested that, in addition to their roles as
a glycolytic enzymes, GAPDH and NNE may be involved in
variety of other cellular events. It has been hypothesized that
glycolytic enzymes exhibit functional duality, the possession of
significant biologic activity in addition to their primary catalytic
role [50, 51]. Several studies suggest that GAPDH has a number
of non-glycolytic functions. These include: (a) association of
GAPDH with microtubules both in vitro [52] and in a human
colonic tumor cell line [53]; (b) demonstration of binding sites for
GAPDH on the actin monomer of microfilaments of rabbit
skeletal muscle [51]; (c) identification of GAPDH as a protein
that catalyzes the formation of the triad junction from isolated
transverse tubules and terminal cisternae in rabbit skeletal muscle
[54]; (d) association of GAPDH with mono- and polyribosomes in
rabbit reticulocytes [55]; (e) interaction of GAPDH with the
erythroid cell membrane resulting in the inhibition of GAPDH
enzymatic activity [56, 57]; (f) identification of GAPDH as a major
surface protein on Group A streptococci [58]; and (g) the
requirement of active GAPDH for the transport of nitric oxide in
platelets [59].
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Fig. 9. Time course of b/NE mRN.4 and protein levels during hypoxia. A.
Normoxic BAEC were either maintained in 21% 02 or exposed to 0% 02
for various lengths of time, as indicated. In certain experiments, after 48
hours in 0% 02, EC were returned to 21% 02 for 24 hours (REOX). Total
RNA was separated on a 1% agarose-formaldehyde gel, transferred to a
nylon membrane and hybridized to a human NNE eDNA probe (middle).
Densitometry values were normalized to -actin (bottom) and expressed
as percent of control (top). B. Time course of NNE mRNA and HAP47
protein levels over increasing time periods of 0% °2 exposure. NNE
mRNA was isolated and analyzed as previously described. Alternatively,
BAEC were exposed to 0% 02 for varying time periods, total protein was
isolated and separated on a 10% SDS-PAGE and [35S1-methionine-
labeled HAP47 levels were assessed by densitometry.
Similar to GAPDH, NNE has been reported to have a number
of non-glycolytic activities. Enolase has been: (1) shown to bind to
F-actin and tubulin [60, 611; (2) localized to the centrosome in
HeLa cells [62, 631; (3) localized to cell-surface membranes in
brain tumor cells [64]; (4) be a lens crystallin in several vertebrates
[65]; (5) shown to undergo axonal transport in guinea pigs [66];
(6) be a plasminogen receptor in a monocytoid cell line [67, 68];
and (7) bind to single stranded DNA in Saccharomyces cerevisiae
in vitro [69].
Enolases may play isoform-specific roles in enhanced mamma-
lian cell survival. For instance, while both NSE and NNE are
present in cultured rat neocortical neurons, only NSE appears to
promote survival [70]. Similarly, NNE may serve a specific func-
tion in promoting EC survival in hypoxia. In this regard, a recent
report suggests an association between enolase and c-myc, a
proto-oncogene that plays a major role in the control of cell
proliferation [71, 72]. This report [72] has identified a 35 to 40
kDa protein, MBP-1, that binds to and may negatively regulate
the P2 promoter of c-myc in HeLa cells. Of interest, the two
oligopeptides obtained in the sequencing of HAP47 were 100%
homologous with MBP-1. Overall, MBP-1 is 79.8% and 68%
homologous with the 215 amino acid carboxy-terminal of human
NSE and NNE, respectively. While this homology may represent
evolutionary co-lineage and not a functional similarity between
these proteins, it is an intriguing possibility that enolase acts as a
transcriptional regulator of c-myc.
These last reports link NNE to nuclear functions. The same
may be true for GAPDH. Several groups have found GAPDH
within the nucleus of certain cell types, including EC, HeLa cells
and oligodendrocytes, using immunocytochemistry [73—75]. Since
glycolysis does not occur within the nucleus, these studies imply
that GAPDH is performing a noncatalytic function within the
nucleus of these cells. In support of this assumption, studies with
a transformed hamster fibroblast cell line have demonstrated that
the DNA-binding protein P8 is, in fact, GAPDH [76]. Moreover,
a study of calf brain has demonstrated that GAPDH binds to
single stranded DNA and suggests that it may play a role as a
GAPDH
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Fig. 10. Effect of hypoxia on GAPDH gene transcription. A. BAEC were
exposed to 21% or 0% °2 for 18 hours. Nuclei were isolated and
[32P]labeled nuclear runoff products were hybridized to denatured eDNA
of the human GAPDH and -actin genes spotted onto nylon membranes.
Actin B. Densitometry of newly transcribed GAPDH levels is shown below
normalized to -aetin levels and expressed as percent of control levels.
The experiment was repeated three times with similar results.
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transcriptional activator during neuronal differentiation [75].
Meyer-Seigler et a! [77] have demonstrated that a nuclear uracil
DNA glycosylase purified from normal human placenta is
GAPDH and that this gene is cell cycle regulated in human
fibroblasts with a characteristic temporal sequence of expression
in relation to DNA synthesis [78]. Finally, Singh and Green [74]
have identified a transfer RNA binding protein as GAPDH.
Taken together, these studies suggest that GAPDH and NNE may
have regulatory functions within the nucleus of several cell types,
including EC.
Using subcellular fractionation techniques in conjunction with
SDS-PAGE we have found that the 36 kDa HAP corresponding
to GAPDH is up-regulated primarily in the cytosol but also in the
nuclear and membrane fractions (Fig. 11) [31]. The 47 kDa HAP
corresponding to NNE was also up-regulated in the cytosolic
fraction in response to hypoxia hut not in the nuclear fraction.
Further analysis using Western blotting showed a 2.3-fold increase
in NNE in the cytosolic fractions (Fig. 12) [321. NNE was
consistently found in the nuclear fractions of EC, however, in
contrast to GAPDH, the level of NNE present in the nuclear
fraction did not change with hypoxia (Fig. 12).
Therefore, GAPDH and NNE may have non-glycolytic func-
tions within EC during their response to hypoxia and this may be
related to EC hypoxia tolerance. Alternatively, GAPDH and
NNE may be involved in other endothelial responses to hypoxia
such as mediators of the synthesis and release of vasoactive
substances, the production of procoagulants, or the release of
mitogenic and chemotactic mediators. The functional significance
of the upregulation of GAPDH, NNE and the other unidentified
HAPs by hypoxia in EC is not yet clear. Determining the roles
they play in hypoxia tolerance requires both the identification of
their transcriptional and translational regulation and the applica-
Fig. 11. Subcellular localization of proteins
induced by hypoxia in EC. Chronically hypoxic
BAEC were maintained in 3% 02 [3] or
exposed to 0% 02 for 18 hours [01. Following
hypoxic exposure cells were placed in 21% 02
for a two hour recovery and then labeled with
[35S1-methionine for one hour. Washed cells
were centrifuged to provide nuclear (NUC),
membrane/cytoplasmic organelle (MEM) and
cytoplasmic (CYTO) fractions, TCA
precipitated, resuspended in Laemmli sample
buffer, separated by 10% SDS-PAGE (loading
equal counts per lane) and analyzed by
autoradiography. The positions of molecular
weight standards are shown at the left and the
position of HAP36 at the right.
C H C H
Nucleus Cytosol
Fig. 12. Subcellular localization of NNE protein duiing hypa'i.a. Nonnoxic BAEC
were maintained in 21% 02 (C) or exposed to 0% 02 for 18 hours (H). After
hypoxic exposure, cells were placed in 21% 02 for two hours, subcellular
fractionation was performed and protein was separated by SDS-PAGE. Western
blotting was performed with a polyclonal antibody directed against NNE.
Densitometric protein levels arc expressed as percent of control.
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tion of these findings to investigate their potential role in the
adaptation of cells to hypoxia.
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